XCO Tech, a specialist in movement, biometric & cognition tracking technology, has confirmed it will receive advisory services and funding of up to $1m (£720,000) from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) over three years.
The cash will be used to advance research and development of embedded AI-based technologies for chronic disease assessment and monitoring.
The use of funds includes support of XCO’s role as the Canadian lead in the INNO4HEALTH multinational consortium led by tech conglomerate Philips and coordinated by R&D cluster programme ITEA3.
The INNO4HEALTH consortium is a $21m (£15.17) project consisting of 37 companies with the common mission of stimulating innovation and the adoption of novel remote monitoring technologies worldwide. XCO will be providing its suite of real-time biometric, cognition, and movement assessment technologies and will work alongside its consortium partners to develop new insights into chronic diseases using artificial intelligence (AI).
Scott McMillan, CEO of XCO, said: “XCO began working with the INNO4HEALTH consortium members prior to COVID-19 because of the value we saw in remote patient monitoring for chronic diseases. The pandemic further validated the need for remote monitoring technologies as they played a pivotal role in the delivery of care to patients from the convenience and safety of their home when healthcare systems were stressed to the max.
“Now, with NRC IRAP’s support, we can play a significant role in ‘remote monitoring 2.0’ and better enable telemedicine companies and other virtual care providers with critical health data. Thus, helping to keep patients out of hospitals, medical clinics, and long-term care facilities.
Some of the proceeds will be used to complete a Virtual Care Patch that is being marketed and sold by the company’s joint venture. The device will provide continuous health monitoring of chronic diseases by measuring vital signs, cognition, and motion as well as leverage unique edge computing AI to deliver novel insights for chronic disease management and early detection of health-threatening events.
The solution will be integrated into XCO’s comprehensive BioAnalytics platform consisting of linkages to healthcare data systems including virtual care, electronic health records, and bioinformatics.
Want to find out more from executives and thought leaders in this space? Find out more about the Digital Twin World event, taking place on 8-9 September 2021, which will explore augmenting business outcomes in more depth and the industries that will benefit.